Slide 1SILEN-C2: sustained virological response (SVR) and safety of BI 201335 combined with peginterferon alfa 2a and ribavirin (PegIFN/RBV) in chronic HCV genotype-1 patients…

Slide 1Boceprevir Combined with Peginterferon alfa-2b/Ribavirin for Treatment-Naïve Patients with HCV Genotype 1 SPRINT-2 Final Results Mark S. Sulkowski, Fred Poordad,…

Slide 1Hepatitis C Treatment in Corrections: New Medicine, New Challenges Spencer Epps, MD, MBA, Medical Director Delaware Department of Correction James Welch, RN, HNB-BC…

Slide 1How to Optimize Treatment of Genotype 4 Patients Rami MOUCARI MD, PhD Bellevue Medical Center – Saint Joseph University, Beirut, Lebanon Slide 2 Case History A 40…

1. THE ROLE OF PEGYLATEDTHE ROLE OF PEGYLATED INTERFERONS IN THEINTERFERONS IN THE MANAGEMENT OF HCVMANAGEMENT OF HCV INFECTIONINFECTION Dr Nasir Khokhar MD FACP FACGDr Nasir…

1. ANTIVIRAL TREATMENTIN CHILDHOOD 2. Some viral illnesses that causemore serious disease, suchas measles, are less common now due towidespread immunization.Most childhood…

LCSP: The Market Medical Unmet Need The Product Address Market Analysis Market opportunity Benchmarking analysis What is the competitive landscape Burden of Disease Natural…

Curing Hepatitis C: Individualized Approach and New Therapies Lorenzo Rossaro, MD Gastroenterology and Hepatology University of California Davis Medical Center c/o  Liver…

1. Generic Nume: Lepirudin Designated Indication: Treatment of heparm-associated thrombocytopenia type II Trade Name (lypresenl): R+ufeiI Date Designated 211311997 Date Approved…

Slide 1 5/14/2015 1 Interim Results from HCV SPRINT-1 Phase 2 Study of Boceprevir Plus Peginterferon alfa-2b/Ribavirin in Treatment-Naïve Subjects with Genotype-1 CHC T.…